Status:
COMPLETED
Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy
Lead Sponsor:
Minia University
Conditions:
Diabetic Retinopathy
Vitreomacular Traction
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The goal of this interventional clinical trial is to assess anatomical and functional outcomes of methotrexate use in irrigating fluid during parsplana vitrectomy combined with intrasilicone injection...
Detailed Description
Tractional macular detachment (TMD) or macula threatening tractional retinal detachment (TRD) and combined tractional-rhegmatogenous retinal detachment (TRD/RRD) are considered as important indication...
Eligibility Criteria
Inclusion
- \- Patients with diabetic tractional macular detachment or combined tractional- rhegmatogenous retinal detachment
Exclusion
- Previous vitreoretinal surgery.
- Pregnant or lactating female.
- Co-existing pathology that might induce PVR such as penetrating ocular trauma or uveitis, co-existing congenital anomalies or hereditary vitreoretinopathies
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06038968
Start Date
September 1 2022
End Date
January 1 2024
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ophthalmology department, Minia university hospital
Minya, Minya Governorate, Egypt, 61519